Patients with pre-existing gastrointestinal conditions, including GERD, peptic ulcer disease, or gastroparesis, should have closer monitoring during GLP-1 initiation and dose escalation
Mfn2/Hsc70 Complex Mediates the Formation of Mitochondria-Lipid Droplets Membrane Contact and Regulates Myocardial Lipid Metabolism
Kenneth Custer, executive vice president and president of Lilly Cardiometabolic Health, said in a statement last year announcing the trial results
While some preclinical research has explored potential immunomodulatory effects of GLP-1 receptor agonists, there is currently insufficient clinical evidence to establish this as a mechanism for systemic symptoms in patients taking tirzepatide
ER and Golgi apparatus were stained using ER-Tracker Red (Fisher Scientific 11584746) diluted 1:2000 and anti-Giantin (BioLegend 908701) 135 diluted 1:500
Carnitine in muscle, serum, and urine of nonprofessional athletes: effects of physical exercise, training, and L-carnitine administration